Timo Soeterik

56 CHAPTER 3 20. Tosoian JJ, Mamawala M, Epstein JI, et al. Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer. J Clin Oncol . 2015 ;33:3379-3385. 21. Eggener SE, Mueller A, Berglund RK, et al. A Multi-Institutional Evaluation of Active Surveillance for Low Risk Prostate Cancer. J Urol . 2013;189:S19-25. 22. Luckenbaugh AN, Auffenberg GB, Hawken SR, et al. Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices. J Urol . 2017;197:621-626. 23. Loeb S, Vellekoop A, Ahmed HU, et al. Systematic review of complications of prostate biopsy. Eur Urol . 2013;64:876-892.

RkJQdWJsaXNoZXIy ODAyMDc0